ACADIA Pharmaceuticals (NASDAQ:ACAD – Get Free Report) released its quarterly earnings results on Tuesday. The biopharmaceutical company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.06 by $0.12, FiscalAI reports. ACADIA Pharmaceuticals had a net margin of 34.30% and a return on equity of 9.61%. The business had revenue […]

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) EVP Elizabeth H.Z. Thompson sold 16,558 shares of the business’s stock in a transaction on Thursday, July 30th. The stock was sold at an average price of $26.13, for a total value of $432,660.54. Following the transaction, the executive vice president owned 18,994 shares of the company’s […]